Developing Therapeutics Against Virtually Any Target with New Antibody Libraries

Don’t get left behind when it comes to mAb discovery

Date & Time

November 18, 2020 | 8 am PDT (5pm CET)

Webinar Description

Monoclonal antibodies have become the preferred therapeutic modality for cancer, infectious diseases, inflammatory and autoimmune disorders, and other conditions.

Twist Bioscience is on a mission to support this work, offering a Library of Libraries containing multiple pre-constructed and validated libraries against many high-value targets with which scientists can build a comprehensive and robust antibody discovery platform.

Here we introduce the latest addition to our Library of Libraries: the Hyperimmune Library.

Join our webinar with Steven Thomas from Twist Biopharma, a division of Twist Bioscience, to:
  • Learn about the Hyperimmune Library for therapeutic development against virtually any target.
  • Hear how the latest libraries are opening new sequence space, allowing researchers to focus on difficult-to-drug targets like GPCRs and ion channels.
  • Review recent work from Twist Biopharma using the Library of Libraries against human ACE2 and the SARS-CoV-2 spike protein to find potently neutralizing candidate antibodies against the SARS-CoV-2 strain of coronavirus in under 4 weeks.
  • Compare options for accessing the Library of Libraries, including licensing or partnering to fully outsource lead discovery.

Webinar Registration

Speaker

Steven Thomas
Business Development Manager, Biopharma | Twist Biopharma, a division of Twist Bioscience
Steven Thomas is the Twist Biopharma Business Development Manager supporting western North America. He graduated from San Diego State University with a B.S and M.S. in Biology. He is trained as a molecular biologist and has extensive experience supporting commercial gene and variant library synthesis. Steven initially joined the Twist Bioscience library team in 2019 as an Application Specialist, helping researchers worldwide identify custom library solutions to facilitate their efforts in protein, antibody, and enzyme engineering. Steven recently joined the Twist Biopharma team, leveraging his in-depth knowledge of combinatorial libraries to support efforts in therapeutic antibody discovery and optimization.
©. All Rights Reserved Twist Bioscience.